Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / SYN - Synthetic Biologics on go with first study of enzyme therapy for gut health

SYN - Synthetic Biologics on go with first study of enzyme therapy for gut health

Synthetic Biologics Inc.
  • The FDA has signed off on a Phase 1 clinical trial evaluating ascending doses of Synthetic Biologics' (SYN +7.4%) SYN-020 in healthy volunteers. The study should launch in Q1 2021.
  • More news on: Synthetic Biologics, Inc., Healthcare stocks news, Stocks on the move,
    • Read more ...
Stock Information
Company Name: Synthetic Biologics Inc.
Stock Symbol: SYN
Market: NYSE
Website: syntheticbiologics.com
Menu
SYN SYN Quote SYN Short SYN News SYN Articles SYN Message Board
Get SYN Alerts

News, Short Squeeze, Breakout and More Instantly...